The study titled " The effectiveness of telemedicine monitoring prehabilitation in prostate cancer patients undergoing radical prostatectomy " investigates the impact of a structured telemedicine-supported prehabilitation and rehabilitation program on reducing postoperative urinary incontinence in patients with localized prostate cancer. Radical prostatectomy, a common treatment for localized prostate cancer, is often associated with complications such as urinary incontinence, which significantly affects quality of life. This study aims to address this issue by enhancing patients' physical conditioning and adherence to pre- and postoperative rehabilitation through the use of wearable devices and remote physiotherapy consultations.
Biopsy-confirmed localized prostate cancer (ICD code C.61).
Indicated for radical prostatectomy, with or without pelvic lymphadenectomy (ePLND).
Not previously treated for prostate cancer, including radiation therapy to the pelvis, major pelvic surgery, or placement of a penile implant or artificial urinary sphincter.
No known urethral stricture or colostomy or chronic urinary catheterization.
Other malignant tumors, except for benign skin carcinoma.
Active treatment for other oncological diagnoses.
Presence of preoperative urinary incontinence.
Diagnosed mental or cognitive disorders.
Parallel
Telemedicine-based prehabilitation and postoperative rehabilitation protocol, including physical activity monitoring, respiratory and postural training, and guidance via telehealth tools.
Other interventionA combination of wearable technology, activity guidelines, educational support, remote monitoring with notifications and consultations with physiotherapists.
Reduction in Early Postoperative Incontinence
Measured by the 24-hour pad weight test.
Time to full Continence Recovery
Time to achieve full continence following surgery (no pads)
Six-Minute Walk Test Distance
Distance that a participant is able to walk in 6 minutes on a hard, flat surface. Unit of Measure: Meters
Balance Test Composite Score
Score from a standardized balance assessment (Berg Balance Scale). Higher scores indicate better balance. Unit of Measure: Score Range: 0-56
EPIC-CP Total Score
Patient-reported outcome measuring health-related QoL in domains relevant to prostate cancer, using the EPIC-CP (Expanded Prostate Cancer Index Composite for Clinical Practice) questionnaire. Higher scores indicate worse QoL. Unit of Measure: Score (0-60)
EQ-5D-5L Index Score
EuroQol (Quality of Life)-5 Dimensions Health status measure based on five dimensions of functioning. Score derived using country-specific value sets. Higher scores represent better health status. Unit of Measure: Score (range: -0.59 to 1)
Forced Expiratory Volume in One Second (FEV1)
FEV1 represents the volume of air that can be forcibly exhaled in the first second of a forced breath. Measurements will be performed using calibrated spirometry according to ERS guidelines. FEV1 is a standard measure of pulmonary function. Higher values indicate better lung function. Unit of Measure: Liters
Maximal Voluntary Ventilation (MVV)
MVV is the maximum amount of air a participant can inhale and exhale within a specific time frame (12 seconds), extrapolated to one minute. Testing will be conducted using standard spirometry under ERS guidelines. MVV reflects respiratory muscle endurance and ventilatory capacity. Unit of Measure: Liters/minute
Click on the lead sponsor to view all of their trials.
University Hospital Olomouc
Lead sponsor
Mobilní fyzioterapie s.r.o.
Collaborator
